March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Retinal Ganglion Cell Survival And Axon Regeneration In Wlds Transgenic Rats After Optic Nerve Crush And Lens Injury
Author Affiliations & Notes
  • Barbara Lorber
    Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
  • Alessia Tassoni
    Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
  • Natalie D. Bull
    Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
  • Marilita M. Moschos
    1st Department of Ophthalmology, University of Athens, Athens, Greece
  • Keith R. Martin
    Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom
  • Footnotes
    Commercial Relationships  Barbara Lorber, None; Alessia Tassoni, None; Natalie D. Bull, None; Marilita M. Moschos, None; Keith R. Martin, None
  • Footnotes
    Support  Fight for Sight
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3486. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Barbara Lorber, Alessia Tassoni, Natalie D. Bull, Marilita M. Moschos, Keith R. Martin; Retinal Ganglion Cell Survival And Axon Regeneration In Wlds Transgenic Rats After Optic Nerve Crush And Lens Injury. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3486.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We have previously shown that the slow Wallerian degeneration mutation (WldS) delays axonal degeneration after optic nerve crush (ONC) but does not protect retinal ganglion cell (RGC) bodies in adult rats. To test whether a combination approach protecting both axons and cell bodies would enhance the therapeutic potential of the Wallerian degeneration mutation we performed ONC and lens injury (LI), which results in both enhanced RGC survival as well as axon regeneration past the lesion site in wildtype animals.

Methods: : Adult Sprague Dawley (SD) or WldS rats received (a) ONC (SD: n=8; WldS: n=9), (b) ONC + LI (SD: n=11; WldS: n=13), or were left untreated (SD: n=8; WldS: n=9). 14 days after treatment, RGC survival (number of Islet+ RGC) and retinal glia activation (intensity of GFAP labeling) were quantified in retinal sections. In addition, the number of GAP43+ RGC axons regenerating past the optic nerve lesion site was assessed.

Results: : As previously reported, we found that the WldS mutation does not protect RGC bodies after ONC alone (SD: 36.6 ± 2.6%; WldS: 36.1 ± 1.6% RGC survival versus untreated). Surprisingly, we found that WldS transgenic rats did not exhibit the enhanced RGC survival response after ONC + LI that was observed in wildtypes (SD: 47.5 ± 2%; P<0.01 versus SD ONC; WldS: 35.2 ± 1.5%). After ONC, only few GAP43+ axons were able to grow past the lesion site in both wildtype and WldS rats (SD: 14.7 ± 5.2; WldS: 18.1 ± 10.8). ONC + LI led to a significant increase in RGC axon regeneration past the lesion site in both wildtype (140.4 ± 29.6; P<0.01 versus ONC) and WldS rats (95.1 ± 35.5; P<0.05 versus ONC), although the difference between wildtype and WldS rats was not statistically significant. Furthermore, activation of retinal glia, previously shown to be associated with enhanced RGC survival and axon regeneration after ONC + LI, was unaffected in WldS transgenic rats (SD: 2.9 ± 0.2; WldS: 2.7 ± 0.2 fold increase over untreated).

Conclusions: : The RGC axon regeneration potential is similar between WldS transgenic and wildtype rats, but WldS transgenic rats do not exhibit enhanced RGC survival after combined ONC + LI suggesting that the neuroprotective effects of LI on RGC survival may be limited by the WldS protein.

Keywords: retina • cell survival • regeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×